The vision of CoLAB TRIALS is to create a unique framework of excellence in clinical research.

Our mission is to increase innovation in the health sector through leveraging the development of innovative health technology products.

We have the ambition to compromisse relevant players working together towards the common objective of strengthening multidisciplinar team’s skills in clinical research.

Major Goals:
To Strengthen and promote knowledge and specialization in trials methodologies to trigger the clinical development of new health technology products from Start-Ups/SME.
Automate data extraction from Health Information Systems for sharing and reuse according to FAIR principles and GDPR.
To disseminate clinical trials relevance and results throughout the community tailored to specific group characteristics.
To provide innovative solutions to conduct clinical research while empowering teams in clinical trial management.

CoLAB TRIALS will be managed
considering a system for value delivery,
ethical principles and values.

in all the actions, communications and
everybody as we would like to be
to guide our work as we guide our lives.
to strenghten team work and engage
to ourselves and to the organization.

José Germano de Sousa


César Fonseca

Universidade de Évora

Inês Alves


Fiscal Council

MC Godinho & Associados
Sociedade de Revisores Oficiais de Contas, Lda.


Carlos Galamba (CHLO)

President of CoLAB TRIALS’ Administration Board

Executive member of the Administration Board of CHLO

President of the Committee for the Personal Data Processing, CHLO

President of the Local Committee for Clinical Digitalization, CHLO

President of the Support Commission for the Operational Intervention Program for the Environmental
Prevention of Legionella, CHLO

Degree in Business Management and Administration, UCP

MSc in Art History (Curricular component) – Universidade Lusíadas

PADIS – Programa de Alta Direcção de Instituições de Saúde, Associação de Estudos Superiores de Empresa (AESE) Business School

Health Economics & Health Technology Assessment  Training Program – Scuola di Direzione Aziendale dell’Università Bocconi (SDA), School of Management , Milan

Francisca Leite
(Luz – GLSMED-Learning Health)

Executive Director, Hospital da Luz Learning Health
Director of Training, Research and Innovation, Luz Saúde
Invited Associate Professor, Faculty of Medicine, UCP
Member of the Dean’s Board at the Faculty of Medicine, UCP
Non-Executive Board Member at UpHill, SA,
PhD in Medical Engineering and Medical Physics, MIT BSc in Engineering Physics, Instituto Superior Técnico

Hélder Dores (NMS)

CoLAB TRIALS Administration Board Member representing NMS|UNL

Researcher at CHRC|NMS|UNL

PhD in Clinical Research (NMS|UNL)

Invited Assistant Professor at NMS|UNL

Coordinator of the Clinical Cardiology, Sports Cardiology and Cardiac Rehabilitation at Hospital da Luz Lisboa

Cardiologist at Human Performance Department of the Sport Lisboa e Benfica

General-Secretary of the Portuguese Society of Cardiology (2021-2023)

Fellow of the European Society of Cardiology

Cardiology Consultant

Aeromedical Medicine Competence (Portuguese Medical Association)

Military Medicine Competence (Portuguese Medical Association)

Medical Doctor Degree (NMS|UNL)

Manuel José Lopes (UÉvora)

Full Professor and Director of the S. João de Deus School of Nursing of the
University of Évora.

Member of the Management Council of the University of Évora

Director of the Doctoral Course in Sciences and Technologies of Health
and Welfare

Researcher at the Comprehensive Health Research Centre and member
of its Board of Directors

Member of the Board of Directors of CoLAB Trials

Member of the Coordination of the Portuguese Observatory of Health

Member of the General Council of the NHS Foundation

Vice-President of the Portuguese Society of Geriatrics and Gerontology

Former Coordinator of the Reform of the NHS for the Area of
Integrated Continued Care

Maria José de Sousa (CML-GS)

Medical Doctor, Clinical Pathologist (MD)

Doctorate in Medicine (PhD) (NMS)

Owner and Chair in Grupo Germano de Sousa;

Chief Medical Officer, Chief of Teaching Department, Chief of Education Department, Chief of Quality Department, Head of Immunology and Autoimmunity Department Head of Pre-Natal Department at Centro de Medicina Laboratorial Germano de Sousa

Elected President of Portuguese Scientific Society for Clinical Pathology

Invited Professor of Integrated Master in Medicine (MIM) of NMS-UNL

Head of Laboratory Medicine Curricular Unit of Integrated Master in Medicine (MIM) (3o year) of NMS-UNL

Coordinator of post-Graduation in Laboratory Medicine (1st to 5th Edition) of the UCP (Portuguese Catholic University)

Head of Curricular Unit “Regulation and Integration” in Master in Medicine (MIM) (1st year) of Catholic Medicine School

Researcher in “EASI- European Autoimmunity Standardization Initiative”

Author/Co-author of 30 scientific published papers in the area of autoimmune diseases, prenatal screening, NIPT, immunology, microbiology.

Heitor Costa (APIFARMA)

Director of Institutional Affairs and Innovation at APIFARMA
Member of the Board of AICIB – Agency for Clinical Research and Biomedical Innovation
Member of the Board of Directors of ISBE – Evidence-Based Health Institute
Member of the Committee for the Evaluation of Medicines at INFARMED
Before in the pharmaceutical field:
Executive Director of APIFARMA;
Director of Institutional Relations, Communication and Market Access at Sanofi
Medical Director of the Medinfar Group
Advisor to the Secretary of State for Health
Director of Medicines and Health Products at INFARMED
Director of Evaluation of Health Products – also performed technical functions at the National Centre of Pharmacovigilance, Technical Committee of Medicines and Surveillance of Health Products
Chaired the Committee for the Evaluation of in vitro Diagnostic Medical Devices, the Working Group on Breast Implants (INFARMED/Direção-Geral da Saúde/Instituto do Consumidor/Ordem dos Médicos) and the Working Group to regulate the dispensing by the ambulatory pharmacies of some medicines dispensed exclusively in the hospital pharmacy (more than 30 representatives of various organizations in the sector)
At EFPIA (European Federation of Pharmaceutical Industries and Associations):
member of the Social and Economic Policy Committee, of the Executive Committee, of the European Markets Committee and of the Group of Directors General of National Associations
At IFPMA (International Federation of Pharmaceutical Manufacturers and Associations), AESGP (Association of the European Self-Care Industry) and at MedTech Europe  was part of the Group of Directors General of National Associations
Member of several committees and working groups of the Council and the Commission of the European Union and of the European Medicines Agency, having chaired the Coordination Group of Market Surveillance Competent Authorities.

Elsa Frazão Mateus (EUPATI-PT)

President of the Board of EUPATI-PT (European Patients’ Academy on Therapeutic

Innovation – Portugal), President of the Board of LPCDR (Portuguese League Against Rheumatic Diseases),
Vice President of EULAR (European Alliance of Associations for Rheumatology) PARE,
EULAR Board member,
Patient Research Partner at EULAR and at LPCDR

Patient Expert in Research & Development of Medicines at LPCDR and EUPATI-PT

EUPATI Fellow Research Member of Comprehensive Health Research Center|NMS|UNL (CHRC)
PhD, Anthropology, UL
MPhil,  Social and Cultural Anthropoloy, UL


Catarina Madeira

Executive Director, CoLAB TRIALS

Researcher at CHRC|NMS|UNL
Clinical Research Manager at NOVA CRU/NMS/UNL (2020-2021)

ECRIN European Correspondent for Clinical Research in Portugal (2015-2019)

Researcher at Institute for Biotechnology and Bioengineering (IBB, IST, UL) (2005-2015)

Collaborator as Lecturer in different MSc, PhD and Post-graduation courses at NMS|UNL and Créteil University, Paris (since 2016)

Author/co-author of 30 scientific publications in Advanced Therapies and Clinical Trials management.

Project Management Professional (PMP), PMI®

PhD Biotechnology, IST, UL

MSc Biotechnology, IST, UL


Diogo Pinto


Cooperation and Funding Manager, CoLAB TRIALS
Involved in the preparation of & 50 proposals for European and Portuguese funding programs over
the last 4 years (10 as coordinator), with > 10 projects approved (3 Europeans as coordinator),
attracting > 7M€ in funding
Project and Customer Manager, LandraTech (2022)
EU programmes manager, Fasttrack Action (2021-2022)
Senior Project Manager, A4F Alga Fuel (2018-2021)
Author/co-author of 3 scientific publications in R&D of Advanced Cellular Therapies
PhD Bioengineering Systems, IST, UL (2018)
MSc Biotechnology, IST, UL (2013)

Fábio Lampreia

Research and Innovation Manager, CoLAB TRIALS
Project Manager/ Scientific Analyst on novel technologies, products, and marketing opportunities for
major Biotechnology companies – PreScouter, Inc. (2019-2022)
Teaching Assistant at Cardiff University (2020)
PhD in Biosciences – Cardiff University, UK (2019)

Researcher assistant at University of Trento, Italy (2014-2015)
MSc in Biotechnology –  Universidade Nova de Lisboa, Portugal (2014)

Anna Braga

Clinical Research Development Manager, CoLAB TRIALS

Clinical Manager – Sleep and Respiratory Care PHILIPS APAC, Singapore; (2021-2022)

Clinical Specialist – ARTICARES Robotics, Singapore (2019-2020)

Clinical Researcher at Faculty of Medicine and Health Sciences – University of Stellenbosch,
South Africa (2016-2018)

Philips Respironics Fellowship in Mechanical Ventilation from the American Respiratory Care
Foundation; New Orleans, LA – USA (2012)

Clinical Researcher at the Clinical and Translational Physiology Unit (Prof Mamede de Carvalho
Lab) – Institute of Molecular Medicine – University of Lisbon, Portugal (2011 – 2019)

PhD in Neurosciences – Faculty of Medicine – University of Lisbon – Portugal (2019)

Masters in Palliative Care – Faculty of Medicine – University of Lisbon – Portugal (2010)

Academic/Professional Equivalence to Degree in Physiotherapy – School of Health Technologies
of Lisbon- Portugal (2001)

Specialization in Locomotor Systems – Escola Paulista de Medicina – Federal University of São
Paulo – Brazil (2000)

Degree in Physiotherapy – Faculty of Physiotherapy – Federal University of Pernambuco – Brazil

Publications in peer review scientific journals on topics related to Non-Invasive Ventilation,
Exercise, Telemedicine and Education of patients and caregivers.

Jorge Neves

Digital Transformation Manager, CoLAB TRIALS

Visiting Assistant Professor at NOVA Information Management School of Universidade Nova de Lisboa
(2009 – Present).

CEO/Founder of Ithaca, Évora, Portugal and Mobnetics, Lisbon, Portugal

Senior Manager at Novabase Business Intelligence, Lisbon, Portugal
(2003–2007), Tactical Intelligence unit manager.

Partner at Novabase GeoInformação, Lisbon, Portugal (2002–2003).

Product/Project Manager at PT Multimedia/SAPO (1999–2002).

CEO/Founder of Imersiva, Lisbon, Portugal (1997–1999), later acquired by Novabase.

Virtual Reality Laboratory Researcher and Manager at GASA – FCT/UNL, Monte de Caparica, Portugal (1993–1997).

Researcher at INESC (1992–1993) and UNINOVA (1989-1992).

As a talented professional, what to expect from CoLAB TRIALS?

You will have the opportunity to integrate a dynamic and motivated team of qualified professionals in different areas of the clinical trials field, where the key word is Collaboration.

With a remarkable sense of team spirit, we will provide you continuous training and networking opportunities with different experts focused on bringing innovation and competitiveness in healthcare within Portugal.

If you identify yourself with our core values and are motivated to participate in a new organization focused on bringing innovation to clinical trials, you should contact us (, sending your CV and a motivation letter and/or apply if any position is opened.


With our associates and partners we have been enhancing a dynamic environment in clinical research by:

  • Triggering the establishment of competitive partnerships within European consortia for Funding Opportunities.
  • Designing, planning and implementing the regulatory roadmap for health product validation and clinical evaluation (TRL >5 – Patented products owned by entrepreneurs, academia, Spin-offs or SMEs).
  • Developing innovative digital solutions and tools for facilitating clinical research by clinical and biomedical investigators and
    health professionals.